Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.77 is 205% above its 5-year average of -0.73, near the high end of its 5-year range (-2.59–0.77).
955.56% above its 12-month average of -0.09.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-27): 0.49.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 14 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:25:46.931Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.77
EARNINGS PER SHARE (EPS) AVG TTM
-0.09
EARNINGS PER SHARE (EPS) AVG 3Y
-1.31
EARNINGS PER SHARE (EPS) AVG 5Y
-0.73
EARNINGS PER SHARE (EPS) AVG 10Y
-0.52
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+955.56%
CURRENT VS 3Y AVG
+158.56%
CURRENT VS 5Y AVG
+205.24%
CURRENT VS 10Y AVG
+248.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Bioventus Inc.
Market Cap
$915.95M
Earnings Per Share (EPS)
0.77
TTM Avg
-0.09
3Y Avg
-1.31
5Y Avg
-0.73
Market Cap
$921.45M
Earnings Per Share (EPS)
0.72
TTM Avg
0.64
3Y Avg
0.54
5Y Avg
0.47
Market Cap
$922.50M
Earnings Per Share (EPS)
0.78
TTM Avg
-0.28
3Y Avg
-0.36
5Y Avg
-0.51
Market Cap
$903.13M
Earnings Per Share (EPS)
-0.64
TTM Avg
-0.60
3Y Avg
-0.67
5Y Avg
-0.65
Market Cap
$942.78M
Earnings Per Share (EPS)
-3.37
TTM Avg
-2.60
3Y Avg
-2.33
5Y Avg
-2.16
Market Cap
$943.26M
Earnings Per Share (EPS)
-1.76
TTM Avg
-1.29
3Y Avg
-1.36
5Y Avg
-1.36
Market Cap
$867.60M
Earnings Per Share (EPS)
-2.18
TTM Avg
-0.78
3Y Avg
-1.63
5Y Avg
-1.49
Market Cap
$856.30M
Earnings Per Share (EPS)
-2.75
TTM Avg
-44.66
3Y Avg
-65.84
5Y Avg
-51.72
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bioventus Inc. (BVS) | $915.95M | 0.77 | -0.09 | -1.31 | -0.73 |
| HealthStream, Inc. (HSTM)vs › | $921.45M | 0.72 | 0.64 | 0.54 | 0.47 |
| Arbutus Biopharma Corp (ABUS)vs › | $922.50M | 0.78 | -0.28 | -0.36 | -0.51 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | -0.64 | -0.60 | -0.67 | -0.65 |
| Kura Oncology, Inc. (KURA)vs › | $942.78M | -3.37 | -2.60 | -2.33 | -2.16 |
| CeriBell, Inc. (CBLL)vs › | $943.26M | -1.76 | -1.29 | -1.36 | -1.36 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | -2.18 | -0.78 | -1.63 | -1.49 |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $856.30M | -2.75 | -44.66 | -65.84 | -51.72 |
| Beta Bionics, Inc. (BBNX)vs › | $852.55M | -1.68 | -1.54 | -1.41 | -1.41 |
Trailing EPS (TTM)
$0.77
Forward EPS (Est.)
$0.78
P/E Ratio
17.6
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.34 |
| 2024-12-31 | -0.52 |
| 2023-12-31 | -2.49 |
| 2022-12-31 | -2.59 |
| 2021-12-31 | 0.43 |
| 2020-12-31 | 0.44 |
| 2019-12-06 | 0.12 |
| 2018-12-31 | -0.22 |
| 2017-12-31 | -0.13 |
| 2016-12-31 | -0.41 |
| 2015-12-31 | -0.69 |
| 2014-12-31 | -0.30 |
| 2013-12-31 | -0.47 |
